Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

Nat Med. 2004 Jun;10(6):617-24. doi: 10.1038/nm1054. Epub 2004 May 23.

Abstract

Bone destruction is a pathological hallmark of several chronic inflammatory diseases, including rheumatoid arthritis and periodontitis. Inflammation-induced bone loss of this sort results from elevated numbers of bone-resorbing osteoclasts. Gene targeting studies have shown that the transcription factor nuclear factor-kappa B (NF-kappa B) has a crucial role in osteoclast differentiation, and blocking NF-kappa B is a potential strategy for preventing inflammatory bone resorption. We tested this approach using a cell-permeable peptide inhibitor of the I kappa B-kinase complex, a crucial component of signal transduction pathways to NF-kappa B. The peptide inhibited RANKL-stimulated NF-kappa B activation and osteoclastogenesis both in vitro and in vivo. In addition, this peptide significantly reduced the severity of collagen-induced arthritis in mice by reducing levels of tumor necrosis factor-alpha and interleukin-1 beta, abrogating joint swelling and reducing destruction of bone and cartilage. Therefore, selective inhibition of NF-kappa B activation offers an effective therapeutic approach for inhibiting chronic inflammatory diseases involving bone resorption.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arthritis, Experimental / immunology
  • Arthritis, Experimental / metabolism
  • Arthritis, Experimental / pathology
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / metabolism
  • Bone Resorption / immunology
  • Bone Resorption / metabolism*
  • Bone and Bones / cytology
  • Bone and Bones / metabolism*
  • Bone and Bones / pathology
  • Carrier Proteins / metabolism
  • Cell Differentiation / physiology
  • Cells, Cultured
  • I-kappa B Proteins / antagonists & inhibitors*
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Interleukin-1 / metabolism
  • Macrophages / cytology
  • Macrophages / metabolism
  • Male
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Osteoclasts / physiology*
  • Peptides / metabolism*
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Signal Transduction / physiology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Carrier Proteins
  • I-kappa B Proteins
  • Interleukin-1
  • Membrane Glycoproteins
  • NF-kappa B
  • Peptides
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Tnfrsf11a protein, mouse
  • Tnfsf11 protein, mouse
  • Tumor Necrosis Factor-alpha